Zobrazeno 1 - 10 of 12 pro vyhledávání: '"Mehnaaz Ali"'
1
Abstract P587: Patients With Diabetes Mellitus and Atrial Fibrillation Affected by Non-Alcoholic Fatty Liver Disease Have Greater Risk of Mortality and Worse Clinical Outcomes
Autor: Leonid Khokhlov, Amr Aboelnasr, Michael Fatuyi, Leanne Pereira, Mehnaaz Ali, Fatima Hussain, Amanda Brown, Kamal Shemisa
Publikováno v: Circulation. 147
Background: Patients with diabetes mellitus (DM) are increasingly affected by AF. Non-Alcoholic Fatty Liver Disease (NAFLD) is an emerging disease and risk factor of interest that predisposes to adverse outcomes. Nevertheless, there is limited scient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e60088c5c1efec8e5ea393837646e00d
https://doi.org/10.1161/circ.147.suppl_1.p587
Zobrazit plný text záznamu
2
Abstract P326: Higher Mortality and Risk for Cardiogenic Shock in Patients With Diabetes Mellitus and Atrial Fibrillation Affected by Pulmonary Hypertension
Autor: Leonid Khokhlov, Amr Aboelnasr, Fatima Hussain, Mehnaaz Ali, Michael Fatuyi, Leanne Pereira, Kamal Shemisa
Publikováno v: Circulation. 147
Background: Population with diabetes mellitus (DM) & atrial fibrillation (AF) is a growing medical problem. Although, pulmonary hypertension (PH) is a recognized entity that poses higher medical risks, there is limited scientific evidence of clinical
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fcee39fb1c53ed9b1700a007644df47b
https://doi.org/10.1161/circ.147.suppl_1.p326
Zobrazit plný text záznamu
3
Abstract P586: Patients With Heart Failure and Chronic Kidney Disease Affected by Pulmonary Hypertension Have Greater Risk of Mortality and Worse Clinical Outcomes
Autor: Leonid Khokhlov, Amanda Brown, Amr Aboelnasr, Michael Fatuyi, Leanne Pereira, Fatima Hussain, Mehnaaz Ali, Kamal Shemisa
Publikováno v: Circulation. 147
Background: Heart failure (HF) and chronic kidney disease (CKD) are increasingly prevalent diseases worldwide. Pulmonary hypertension (PH) is a known predictor of adverse outcomes. Nevertheless, there is limited scientific evidence of clinical outcom
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::37c21da0e421657266effd4f75b7d7a5
https://doi.org/10.1161/circ.147.suppl_1.p586
Zobrazit plný text záznamu
4
Abstract P325: Adverse Clinical Outcomes in Non-Alcoholic Fatty Liver Disease Patients Admitted With Heart Failure and Chronic Kidney Disease
Autor: Leonid Khokhlov, Amr Aboelnasr, Leanne Pereira, Michael Fatuyi, Mehnaaz Ali, Fatima Hussain, Amanda Brown, Kamal Shemisa
Publikováno v: Circulation. 147
Background: Patients with heart failure (HF) are increasingly affected by (CKD). There is a growing evidence connecting Non-Alcoholic Fatty Liver Disease (NAFLD) with poor health outcomes. Nevertheless, there is limited scientific evidence of clinica
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b8054b83886b4616d4e4764fea49e646
https://doi.org/10.1161/circ.147.suppl_1.p325
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje